Related Experiment Video
Updated: May 27, 2026

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria
Published on: July 6, 2013
Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic
Sara Leschner1, Igor V Deyneko, Stefan Lienenklaus
1Molecular Immunology, Helmholtz Centre for Infection Research, Inhoffenstr. 7, 38124 Braunschweig, Germany. sara.leschner@helmholtz-hzi.de
Abstract:
Conventional cancer therapies are often limited in effectiveness and exhibit strong side effects. Therefore, alternative therapeutic strategies are demanded. The employment of tumor-colonizing bacteria that exert anticancer effects is such a novel approach that attracts increasing attention. For instance, Salmonella enterica serovar Typhimurium has been used in many animal tumor models as well as in first clinical studies. These bacteria exhibit inherent tumoricidal effects. In addition, they can be used to deliver therapeutic agents. However, bacterial expression has to be restricted to the tumor to prevent toxic substances from harming healthy tissue. Therefore, we screened an S. Typhimurium promoter-trap library to identify promoters that exclusively drive gene expression in the cancerous tissue. Twelve elements could be detected that show reporter gene expression in tumors but not in spleen and liver. In addition, a DNA motif was identified that appears to be necessary for tumor specificity. Now, such tumor-specific promoters can be used to safely express therapeutic proteins by tumor-colonizing S. Typhimurium directly in the neoplasia.
Insights
Researchers identified novel tumor-specific promoters in Salmonella Typhimurium bacteria. These promoters enable targeted gene expression within tumors, enhancing the safety of bacterial cancer therapies.
Area of Science:
- Microbiology
- Oncology
- Biotechnology
Background:
- Conventional cancer therapies face limitations in efficacy and present significant side effects.
- Tumor-colonizing bacteria, such as Salmonella Typhimurium, offer a novel therapeutic strategy with inherent anticancer effects and potential for targeted drug delivery.
- Ensuring tumor-specific bacterial gene expression is crucial to prevent systemic toxicity.
Purpose of the Study:
- To identify bacterial promoters that drive gene expression exclusively within tumor tissues.
- To develop safer bacterial cancer therapies by restricting therapeutic agent production to the tumor site.
Main Methods:
- Screening of a Salmonella Typhimurium promoter-trap library.
- Utilizing reporter gene assays to evaluate promoter activity in tumor tissues versus healthy organs (spleen and liver).
- Identification of specific DNA motifs associated with tumor specificity.
Main Results:
- Twelve promoter elements were identified that demonstrated exclusive reporter gene expression in tumors.
- No significant reporter gene expression was observed in the spleen and liver for these identified elements.
- A DNA motif critical for achieving tumor specificity was discovered.
Conclusions:
- Tumor-specific promoters have been identified in S. Typhimurium, enabling targeted gene expression within cancerous tissues.
- These promoters can be utilized to safely express therapeutic proteins via tumor-colonizing bacteria, minimizing off-target effects.
- This research advances the development of safer and more effective bacterial-based cancer therapies.
More Related Videos
13:48Discovering CsgD Regulatory Targets in Salmonella Biofilm Using Chromatin Immunoprecipitation and High-Throughput Sequencing (ChIP-seq)
Published on: January 18, 2020
10:57NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
Related Concept Videos
The Eukaryotic Promoter Region
Reporter Genes
Commonly used reporter...
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Regulation of Bacterial Virulence
Gene Regulation During Sporulation